A Category 1 BPC-157 is still an unapproved drug just one that compounders can legally dispense under specific conditions
Discover how GLP-1 therapy is helping Jamaicans achieve sustainable weight loss through science-backed medical care
Altimmune is advancing pemvidutide, a dual agonist targeting both obesity and liver disease, differentiating itself through a multiindication strategy that contrasts with the more obesitycentric portfolios of Novo and Lilly
Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, et al
Although -synuclein is frequently implicated in PD pathogenesis, other proteins such as PTEN induced putative kinase 1 (PINK1), Parkin, DJ-1, leucine-rich repeat kinase 2 (LRRK2) have been strongly linked to familial forms of PD 6,7